Quantitative analysis for Immatics N.V. (IMTX) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Hold (47.0) (grade C). 28 signals analyzed (24 differentiated alt-data).
IMTX stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $11.65 | $11.00 | $11.20 |
| 2026-05-11 | $11.94 | $11.39 | $11.54 |
| 2026-05-21 | $11.36 | $10.96 | $11.06 |
| 2026-06-03 | $10.21 | $9.70 | $10.21 |
| 2026-06-15 | $9.67 | $9.33 | $9.43 |
| 2026-06-26 | $9.73 | $9.27 | $9.52 |
| 2026-07-09 | $10.10 | $9.79 | $9.96 |
| 2026-07-21 | $9.48 | $9.22 | $9.41 |
| 2026-07-31 | $9.20 | $8.57 | $8.66 |
| 2026-08-12 | $9.91 | $9.59 | $9.71 |
| 2026-08-24 | $8.86 | $8.56 | $8.69 |
| 2026-09-03 | $9.69 | $9.26 | $9.46 |
How Immatics N.V. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| ATAI | Atai Beckley N.V | $1.5B | — |
| IMCR | Immunocore Holdings plc | $1.5B | — |
| QURE | uniQure N.V. | $1.5B | 38.0 |
| GHRS | GH Research PLC | $1.5B | 38.0 |
View all Health Care stocks by valuation and signals →
Immatics N.V. (IMTX) scores Hold (47.0), and the composite conceals a 55-point disagreement between its dimensions. It is strongest on analyst consensus at 90 and valuation at 72, and weakest on technicals at 35. A stock can carry analyst consensus that high while technicals sits at 35; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| analyst consensus | 90 |
| valuation | 72 |
| technicals | 35 |
StoQuant analyzes 28 signals (24 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Immatics N.V. (IMTX): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/IMTX"><img src="https://stoquant.com/badge/IMTX.svg" alt="Immatics N.V. (IMTX) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.